Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results

Galmed Pharma (GLMD) Tops Q3 EPS by 8c

November 6, 2019 7:23 AM EST

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29).

Financial Summary - Third Quarter 2019 vs. Third Quarter 2018:

Cash and cash equivalents, short-term deposits and marketable securities totaled $79.7 million as of September 30, 2019, compared to $90.2 million at December 31, 2018.Net loss of $4.5 million, or ($0.21) per share, for the three months ended September 30, 2019, compared to a net loss of $1.0 million, or ($0.05) per share, for the three months ended September 30, 2018.Research and... More